Thrombotic complications are a hallmark of antiphospholipid syndrome (APS). These
vascular–arterial, venous, and/or small vessel–complications are well described and known …

The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …

Various hematological pathologies have been described in association with
antiphospholipid syndrome (APS). Thrombocytopenia is frequently found in APS patients, its …

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …

The concept of “probable” antiphospholipid syndrome (APS) is almost identical with several
conditions which may presage the development of the APS with its major complications of …

The catastrophic antiphospholipid syndrome (CAPS) is a rare disease that affects 1% of
cases with antiphospholipid syndrome (APS). CAPS can mimic or overlap with different …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
clinical association of antiphospholipid autoantibodies (aPL) with a syndrome of …

Antiphospholipid syndrome (APS) is a disorder characterized by a wide variety of clinical
manifestations. Virtually any organ system or tissue may be affected by the consequences of …

Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …

Antiphospholipid syndrome (APS) is an autoimmune thrombophilia propelled by circulating
antiphospholipid antibodies that herald vascular thrombosis and obstetrical complications …